A new member of the BOVILIS® NASALGEN® family is now available. This vaccine offers protection for beef and dairy cattle against critical BRD-causing pathogens, all with no risk of injection site reactions.
Choose your level of protection:
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza 3 virus, Mannheimia haemolytica and Pasteurella multocida.
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza 3 virus.
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 5 months of age or older against disease caused by IBR and PI3 virus.
Why Choose BOVILIS NASALGEN?
Benefits of Intranasal Technology
Different forms of vaccinations can and will affect animals differently – which makes your job choosing vaccines that will set animals up for a lifetime of healthy production all the more important.
Thanks to further research done by Dr. Philip Griebel, professor and research chair in neonatal mucosal immunology at the University of Saskatchewan School of Public Health, we now know the benefits of intranasal vaccination make a much bigger difference than originally thought.
Real-world stories of BOVILIS® NASALGEN® 3 vaccine results.
Learn how vaccination strategies protect beef and dairy calves against BRD.
Research
Learn how Merck Animal Health works to keep you ahead of the curve with BOVILIS NASALGEN vaccines.
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza 3 virus, Mannheimia haemolytica and Pasteurella multocida.
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 1 week of age or older against infectious Bovine Rhinotracheitis (IBR) virus, Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza 3 virus.
Intranasal vaccine shown to be effective for the vaccination of healthy cattle 5 months of age or older against disease caused by IBR and PI3 virus.
For more cattle-friendly options, see the rest of the Merck Animal Health vaccine lineup.
Sign up to receive cattle health management insights, industry news and more sent straight to your inbox.